Skip to main content

Viberzi Prices, Coupons, Copay Cards & Patient Assistance

Viberzi (eluxadoline) is a member of the peripheral opioid receptor mixed agonists/antagonists drug class and is commonly used for Diarrhea, Irritable Bowel Syndrome, and Irritable Bowel Syndrome with Diarrhea.

The cost for Viberzi 75 mg oral tablet is around $1,805 for a supply of 60 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Viberzi is available as a brand name drug only, a generic version is not yet available. View generic Viberzi availability for more details.

Viberzi prices

Oral Tablet

75 mg

Viberzi oral tablet

 from $1,804.87

for 60 tablets
Quantity Per unit Price
60 $30.08 $1,804.87

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

100 mg

Viberzi oral tablet

 from $1,804.87

for 60 tablets
Quantity Per unit Price
60 $30.08 $1,804.87

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Viberzi Coupons, Copay Cards and Rebates

Viberzi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Viberzi Savings Program

Eligible commercially insured patients may pay $30 per 30-day prescription with a maximum savings of $10,771.00 per calendar year.

Applies to:
Viberzi
Number of uses:
12 times within calendar year

Form more information phone: 844-453-3487 or Visit website

Healthcare providers may obtain a FREE trial offer of Viberzi for their patients by calling 800-678-1605.

Applies to:
Viberzi
Number of uses:
Contact the program

Form more information phone: 800-678-1605 or Visit website

Healthcare providers may obtain a FREE samples of Viberzi for their office by logging onto MySampleCloset.com.

Applies to:
Viberzi
Number of uses:
Contact the program

Form more information phone: 800-678-1605 or Visit website

Patient Assistance & Copay Programs for Viberzi

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: myAbbVie Assist for Creon, Linzess, Viberzi

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 600% of FPL
  3. Not applicable
  4. Must be a US resident and treated by a US licensed healthcare provider
  5. Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis.
Applicable drugs:
  • Viberzi (eluxadoline) Tablet

More information please phone: 800-222-6885 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.